Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Pomerantz Roger Create: Alert

All | News | Filings
Date FiledTypeDescription
08/18/2023 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $1.23, valued at $18.5k
06/09/2023 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $1.5, valued at $60k
05/26/2023 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 9,035 restricted stock units @ $0
02/28/2023 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 9,034 restricted stock units @ $0
11/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/29/2022 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 9,034 restricted stock units @ $0
08/11/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2022 4 Pomerantz Roger (CEO) has filed a Form 4 on CONTRAFECT Corp
Txns: Granted 500,000 options to buy @ $3.33, valued at $1.7M
11/29/2021 4 Pomerantz Roger (Director) has filed a Form 4 on Viracta Therapeutics, Inc.
Txns: Exercised 18,068 restricted stock units @ $0
08/06/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/13/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/30/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/17/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/24/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/02/2019 4 Pomerantz Roger (Director) has filed a Form 4 on Intec Pharma Ltd.
Txns: Granted 20,000 options to buy @ $4.858, valued at $97.2k
06/14/2019 4 Pomerantz Roger (Director) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $2.83, valued at $42.5k
04/04/2019 4 Pomerantz Roger (CEO) has filed a Form 4 on CONTRAFECT Corp
09/11/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Sold 1,810 shares @ $9.0007, valued at $16.3k
09/06/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Sold 9,505 shares @ $9.123, valued at $86.7k
Sold 3,013 shares @ $9.0393, valued at $27.2k
07/23/2018 4 Pomerantz Roger (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Bought 100 shares @ $23, valued at $2.3k
07/18/2018 4 Pomerantz Roger (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $23, valued at $575k
07/12/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Sold 1,010 shares @ $9.0089, valued at $9.1k
Exercised 1,010 options to buy @ $0.71, valued at $717.1
07/10/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Sold 15,366 shares @ $9.144, valued at $140.5k
Sold 10,981 shares @ $9.1386, valued at $100.4k
Sold 5,989 shares @ $9.0512, valued at $54.2k
Exercised 15,366 options to buy @ $0.71, valued at $10.9k
Exercised 10,981 options to buy @ $0.71, valued at $7.8k
Exercised 5,989 options to buy @ $0.71, valued at $4.3k
06/29/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Sold 21,560 shares @ $9.1547, valued at $197.4k
Sold 4,496 shares @ $9.1004, valued at $40.9k
Exercised 21,560 options to buy @ $0.71, valued at $15.3k
Exercised 4,496 options to buy @ $0.71, valued at $3.2k
06/27/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Sold 26,752 shares @ $9.2144, valued at $246.5k
Sold 21,224 shares @ $9.194, valued at $195.1k
Sold 16,991 shares @ $9.0288, valued at $153.4k
Exercised 16,288 options to buy @ $0.71, valued at $11.6k
Exercised 21,224 options to buy @ $0.71, valued at $15.1k
Exercised 16,991 options to buy @ $0.71, valued at $12.1k
06/22/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Sold 26,492 shares @ $9.3255, valued at $247.1k
Sold 18,987 shares @ $9.0638, valued at $172.1k
Sold 40,057 shares @ $9.3557, valued at $374.8k
05/10/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Sold 233 shares @ $9, valued at $2.1k
05/10/2018 4 Pomerantz Roger (Director) has filed a Form 4 on CONTRAFECT Corp
01/30/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Granted 278,000 options to buy @ $10.42, valued at $2.9M
01/25/2018 4 Pomerantz Roger (President and CEO) has filed a Form 4 on Seres Therapeutics, Inc.
Txns: Exercised 40,241 options to buy @ $0.71, valued at $28.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy